Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
Condition(s):Macular Edema; Epiretinal Membrane; VitrectomyLast Updated:October 3, 2018Terminated
Hide Studies Not Open or Pending
Condition(s):Macular Edema; Epiretinal Membrane; VitrectomyLast Updated:October 3, 2018Terminated
Condition(s):Multiple MyelomaLast Updated:February 15, 2017Withdrawn
Condition(s):COVID-19; Acute Respiratory Distress Syndrome; Pneumonia, ViralLast Updated:March 1, 2023Recruiting
Condition(s):Hypersensitivity ReactionLast Updated:October 23, 2020Completed
Condition(s):Covid19; DexamethasoneLast Updated:March 1, 2023Not yet recruiting
Condition(s):CancerLast Updated:April 28, 2020Completed
Condition(s):Dexamethasone; Supraclavicular Brachial Plexus BlockLast Updated:February 6, 2017Unknown status
Condition(s):Epiretinal Membrane; Macular EdemaLast Updated:July 27, 2016Terminated
Condition(s):Irreversible PulpitisLast Updated:March 9, 2023Recruiting
Condition(s):MigraineLast Updated:September 7, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.